Put Options Transactions Made in Q4 2023 in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during Q4 2023. The information is specifically focused on institutions that hold put options of BIOCRYST PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
PUT |
124K+ 149.52% |
$617K - $838K
|
207K
$1.57M
|
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
PUT |
60KNew |
$299K - $406K
|
60K
$456K
|
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
PUT |
50KNew |
$249K - $339K
|
50K
$380K
|
|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
BUY
|
PUT |
9.9K+ 82.5% |
$49.3K - $67K
|
21.9K
$166K
|
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
PUT |
-1.3K- 0.99% |
$6.47K - $8.8K
|
130K
$984K
|
|
|
Feb 14, 2024
Q4 2023
|
Gts Securities LLC
New York, NY |
SELL
|
PUT |
-4.5K- 28.48% |
$22.4K - $30.5K
|
11.3K
$85.9K
|
|
|
Feb 14, 2024
Q4 2023
|
Walleye Trading LLC
Plymouth, MN |
SELL
|
PUT |
-10.7K- 67.72% |
$53.3K - $72.4K
|
5.1K
$38.8K
|